Menu Search
Equities

Grace Therapeutics, Inc

GRCE:NAQ

Grace Therapeutics, Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.05
  • Today's Change-0.14 / -4.39%
  • Shares traded29.90k
  • 1 Year change+41.86%
  • Beta1.4898
Data delayed at least 15 minutes, as of Nov 13 2024 20:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, cash reserves at Grace Therapeutics, Inc fell by 4.87m. Cash Flow from Financing totalled 7.36m or -- of revenues. In addition the company used 12.33m for operations while cash from investing totalled 104.00k.
Cash flow per share-1.16
Price/Cash flow per share--
Book value per share5.85
Tangible book value per share0.9959
More ▼

Balance sheet in USDView more

Grace Therapeutics, Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio7.86
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.